Biblio
Export 1190 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is D [Clear All Filters]
“Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.”, J Alzheimers Dis, vol. 51, no. 2, pp. 427-37, 2016.
, “Dementia Apraxia Test (DATE): A Brief Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Dementia Based on Apraxia Profiles.”, J Alzheimers Dis, vol. 49, no. 3, pp. 593-605, 2016.
, “A Depressive Endophenotype for Predicting Cognitive Decline among Mexican American Adults and Elders.”, J Alzheimers Dis, vol. 54, no. 1, pp. 201-6, 2016.
, “Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1065-80, 2016.
, “Development of a Proxy-Free Objective Assessment Tool of Instrumental Activities of Daily Living in Mild Cognitive Impairment Using Smart Home Technologies.”, J Alzheimers Dis, vol. 52, no. 2, pp. 509-17, 2016.
, “Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?”, J Alzheimers Dis, vol. 54, no. 4, pp. 1297-1302, 2016.
, “Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1287-97, 2016.
, “Diagnostic Distortions: A Case Report of Progressive Apraxia of Speech.”, J Alzheimers Dis, vol. 53, no. 1, pp. 79-83, 2016.
, “Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 97-106, 2016.
, “Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1069-83, 2016.
, “Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.”, J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
, “Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1011-22, 2016.
, “The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1051-64, 2016.
, “Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1003-22, 2016.
, “Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 669-78, 2016.
, “Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 669-78, 2016.
, “Effect of Early Referral to Specialist in Dementia on Institutionalization and Functional Decline: Findings from a Population-Based Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 819-28, 2016.
, “Effect of Normal Aging and of Mild Cognitive Impairment on Event-Related Potentials to a Stroop Color-Word Task.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1487-501, 2016.
, “Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial.”, J Alzheimers Dis, vol. 54, no. 1, pp. 129-33, 2016.
, “Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.”, J Alzheimers Dis, vol. 50, no. 1, pp. 271-82, 2016.
, “Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?”, J Alzheimers Dis, vol. 52, no. 3, pp. 1125-33, 2016.
, “Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 921-32, 2016.
, “Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 921-32, 2016.
, “Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 921-32, 2016.
, “Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).”, J Alzheimers Dis, vol. 53, no. 4, pp. 1365-73, 2016.
,